家族企业数字化与内部控制环境建设——以康美药业财务造假为例
Construction of Digitization and Internal Control Environment in Family Enterprises—A Case Study of Kangmei Pharmaceutical Financial Fraud
摘要: 随着改革开放的不断推进,中国的民营企业逐渐如雨后春笋般涌现出来,其中,家族企业在民营企业中占据了很大的比重。然而,采用集权结构的家族企业弊端也开始显现出来,这其中往往伴随着因为企业数字化建设缺失而导致的财务造假问题,不但损害了相关人员的权益,也破坏了公平。本文以康美药业财务造假案为研究对象,旨在分析家族企业数字化与内部控制之间的关系,并通过加强数据管理,健全信息技术治理结构,强化ERP系统应用,提高风险管理等方面来加强家族企业的数字化建设,从而改善企业内部控制环境,继而降低企业财务造假风险,这对于提升我国家族企业信誉,促进市场健康发展具有重要意义。
Abstract: With the implementation of China’s reform and opening up, there are more and more private enterprises. Among them, family businesses account for a large part. However, the disadvantages of family enterprises with centralized structure also begin to appear, which is often accompanied by financial fraud caused by the lack of digital construction of enterprises, which not only damages the rights and interests of stakeholders, but also disturbs the market. This paper takes the financial fraud case of Kangmei Pharmaceutical as the research object, aiming to analyze the relationship between digitalization and internal control of family enterprises, and strengthen the digitalization construction of family enterprises by strengthening data management, improving the information technology governance structure, strengthening the application of ERP system, improving risk management and other aspects, so as to improve the internal control environment of enterprises and reduce the risk of financial fraud of enterprises. It is of great significance to enhance the reputation of family enterprises and promote the healthy development of the market.
参考文献
|
[1]
|
Nwankpa, J.K. and Roumani, Y. (2016) IT Capability and Digital Transformation: A Firm Performance Perspective. Thirty Seventh International Conference on Information Systems, Dublin, 1-16.
|
|
[2]
|
柳志南. 数字化转型有助于企业抑制内部控制缺陷吗? [J]. 暨南学报(哲学社会科学版), 2024, 46(4): 97-112.
|
|
[3]
|
程莉雅, 胡秀群. 企业数字化发展驱动下的内部控制质量提升效应研究[J]. 现代管理科学, 2022(6): 111-119.
|
|
[4]
|
郜保萍. 企业数字化转型与内部控制有效性[J]. 会计之友, 2023(4): 127-133.
|
|
[5]
|
Akomea-Frimpong, I. and Andoh, C. (2020) Understanding and Controlling Financial Fraud in the Drug Industry. Journal of Financial Crime, 27, 337-354. [Google Scholar] [CrossRef]
|
|
[6]
|
Chalmers, K., Hay, D. and Khlif, H. (2018) Internal Control in Accounting Research: A Review. Journal of Accounting Literature, 42, 80-103. [Google Scholar] [CrossRef]
|
|
[7]
|
麦志安, 于成学, 陈远麟, 张晓莹, 钟楚瑶, 陈泳瑶. 药业上市公司财务风险及内控研究——以康美药业财务造假为例[J]. 现代商业, 2021(30): 142-147.
|
|
[8]
|
梁畅舟. 康美药业财务造假分析——基于内部控制视角[J]. 老字号品牌营销, 2021(10): 83-84.
|
|
[9]
|
汤卫伟. 风险管理视角下中小企业内部控制环境的建立分析[J]. 哈尔滨学院学报, 2021, 42(3): 28-30.
|
|
[10]
|
赵唯一. 企业数字化转型文献综述[J]. 海峡科技与产业, 2023, 36(12): 24-28.
|
|
[11]
|
马锦, 乔鹏程. 企业内部控制环境研究文献综述[J]. 商业会计, 2016(2): 55-57.
|
|
[12]
|
搜狐. 总投资300亿元, 康美昆明健康城何去何从? [EB/OL]. 2019-05-28. https://www.sohu.com/a/317095988_345608, 2024-09-16.
|
|
[13]
|
杨乐. 企业财会管理中的风险防范与控制策略探讨[J]. 财会学习, 2024(21): 26-28.
|
|
[14]
|
齐梦晓. 风险管理视角下康美药业内部控制问题研究[D]: [硕士学位论文]. 徐州: 中国矿业大学, 2021.
|
|
[15]
|
沈鑫炜. 上市公司多重监督失效及其防范研究[D]: [硕士学位论文]. 杭州: 浙江工商大学, 2021.
|